Metraipolis › archive › dc_8d3184bb3cfc
Activation of AMPK as a therapeutic strategy for FBXL4-related mitochondrial DNA depletion syndrome — Europe PMC PMID:42310391
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42310391
- DOI
- 10.1038/s44321-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:51:23.915Z
- SHA-256 of the archived text
46fabea15be5025925c7c7b8d70af64f8d8df720b917f601949446d3bf219a4f- Stable URL of this page
https://metraipolis.com/documento/dc_8d3184bb3cfc
How to cite
Activation of AMPK as a therapeutic strategy for FBXL4-related mitochondrial DNA depletion syndrome — Europe PMC PMID:42310391 — Europe PMC (en), https://europepmc.org/article/MED/42310391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d3184bb3cfc (Metraipolis archive dc_8d3184bb3cfc, sha256 46fabea15be5025925c7c7b8d70af64f8d8df720b917f601949446d3bf219a4f)
BibTeX
@misc{dc8d3184bb3cfc,
title = {Activation of AMPK as a therapeutic strategy for FBXL4-related mitochondrial DNA depletion syndrome — Europe PMC PMID:42310391},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42310391},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d3184bb3cfc; sha256 46fabea15be5025925c7c7b8d70af64f8d8df720b917f601949446d3bf219a4f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42310391. Agents can read the archived copy with the MCP tool read_document.